West Pharmaceutical Services Inc.
WST | NYSE
$412.62
-$4.05 (-0.97%)
At close: Oct 30, 2026, 4:00 PM ET
$414.18
+$1.56 (+0.38%)
Pre-market:
Nov 2, 2026, 7:33 AM ET
Market Data
Market Cap $29.04B
Enterprise Value $28.88B
Beta 1.13
Average Volume 662.06K
Shares Outstanding (Diluted) 70.8M
Shares Change YoY -2.61%
Institutional Ownership 98.70%
Exchange NYSE
ISIN US9553061055
Price Performance
Price Change 1M 11.3%
Price Change 3M 21.0%
Price Change 6M 37.2%
Price Change YTD 50.0%
Price Change 1Y 46.3%
Price Change 3Y 29.6%
Price Change 5Y -4.0%
1M CAGR (ann.) 13.9%
1Y CAGR (ann.) 45.3%
5Y CAGR (ann.) -0.1%
All-Time CAGR 18.8%
Valuation
PE Ratio 46.31
Forward PE 39.62
PEG Ratio 1.43
Forward PEG 1.55
PS Ratio 8.55
Forward PS 8.10
PB Ratio 9.78
P/FCF Ratio 64.05
P/Adj. FCF Ratio 68.34
P/OCF Ratio 44.37
EV/Sales 8.50
EV/EBIT 36.87
EV/EBITDA 29.87
EV/FCF 63.70
Earnings Yield 2.2%
FCF Yield 1.6%
Adj. FCF Yield 1.5%
Financial Health
Net Cash $261.2M
Total Debt $305M
Cash & Short-Term Investments $464.1M
Total Assets $4.06B
Current Ratio 2.82
Quick Ratio 2.10
Debt / Equity Ratio 0.10
Debt / EBITDA 0.32
Debt / FCF 0.67
OCF / Debt 2.15
Interest Coverage 0.00
Altman Z-Score 19.27
Piotroski F-Score 7
Margins & Profitability
Gross Profit Margin 37.6%
Operating Profit Margin 23.0%
EBITDA Margin 28.5%
Net Profit Margin 18.8%
FCF Margin 13.3%
Adj. FCF Margin 12.5%
SBC / Revenue 0.8%
SBC Impact (per share) -6.3%
Returns
Return on Assets 15.7%
Return on Equity 21.1%
Return on Invested Capital 17.9%
Return on Capital Employed 22.8%
Return on Tangible Assets 16.2%
Historical Growth (CAGR)
Revenue CAGR 3Y 5.1%
Revenue CAGR 5Y 4.8%
Revenue CAGR 10Y 8.6%
EPS CAGR 3Y 6.3%
EPS CAGR 5Y 2.0%
EPS CAGR 10Y 17.0%
FCF CAGR 3Y 2.6%
FCF CAGR 5Y 5.9%
FCF CAGR 10Y 25.1%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 8
EPS Growth Next 3Y 14.2%
Revenue Growth Next 3Y 7.3%
Earnings Date Feb 11, 2027
EPS Estimate (next Q) $2.27
EPS Growth Est (next Q) 11.3%
Revenue Est (next Q) $824.95M
Revenue Growth Est (next Q) 2.5%
Fair Value Estimates
Graham Number $91.93
Graham Upside -77.7%
Lynch Fair Value $44.55
Lynch Upside -89.2%
Price Target $419.50
Price Target Upside 1.7%
Cash Flow
Operating Cash Flow $654.5M
Free Cash Flow $453.4M
Adj. Free Cash Flow $424.9M
FCF Per Share $6.44
OCF Per Share $9.30
OCF/S Ratio 19.3%
Income Statement
Revenue $3.4B
Gross Profit $1.28B
Operating Income $780.2M
EBITDA $966.9M
Net Income $638.9M
EPS (Diluted) $8.91
Revenue / Employee $314.51K
Profit / Employee $59.16K
Employees 10,800
Dividends
Annual Dividend $0.88
Dividend Yield 0.21%
Payout Ratio 9.9%
FCF Payout Ratio 13.8%
Adj. FCF Payout Ratio 14.8%
Dividend Growth (YoY) 4.8%
Pay Frequency Quarterly
Ex-Dividend Date Nov 10, 2026
Add to Watchlist
Select watchlists to add or remove WST